Celldex Therapeutics (CLDX) - Earnings growth in current year
Celldex Therapeutics (CLDX) faces cash burn risks and a dependence on clinical trial outcomes while operating under intense pressure from biotech behemoths. This chart of annual earnings per share changes clearly illustrates the dynamics of this process, where -4.60 represents the current level of the metric. The company's prospects are supported by expanding demand for severe inflammation therapies.
Financial and market metric breakdowns for Celldex Therapeutics (CLDX)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Equity Ratio Celldex Therapeutics|CLDX - Long-Term Debt to Capital|Current Liabilities to Capital celldex.com|CLDX - Company Debts|Debt to Book Capitalization Ratio Celldex Corp|CLDX - Company Long-Term Debt|Company Short-Term Debt Celldex Therapeutics|Immediate Liquidity Ratio celldex.com
- earnings and market ratios statistics:
CLDX - Net Profit|Expected Net Profit Celldex Therapeutics|CLDX - Price to Earnings Ratio|Price to Future Earnings Ratio Celldex Corp|CLDX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Celldex Corp|CLDX - Operating profit before deduction of amortization|Earnings per share for the last four quarters Celldex Therapeutics|CLDX - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months celldex.com|CLDX - Earnings growth in current year|Expected net earnings per share growth next year Celldex Therapeutics
Basic company analysis:Celldex Therapeutics Inc, CLDX
This indicator measures the annual growth rate of earnings per share, allowing for an assessment of business capitalization efficiency and the company's ability to generate real income. By analyzing the year-over-year earnings per share trend, an investor can promptly detect a cooling of growth rates, which is critical for Celldex (CLDX) as it progresses through clinical trial stages and seeks regulatory approvals.
Main competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|Grifols Group - Earnings growth in current year|Adaptive Biotechnologies Inc. (ADPT) - Net earnings per share growth this year|AUPH: Earnings growth in current year|Earnings per share growth rate in current year biocryst.com (BCRX)|Earnings per share growth in current year Vera Therapeutics|Earnings per share growth in current year DNTH|Earnings per share growth in current year Pharvaris Corp (PHVS)|Earnings per share growth in current year ABCL (AbCellera Bio)|Earnings growth in current year TRML (Tourmaline Bio, Inc.)|PGEN: Earnings per share growth this year|Pharming Group - Earnings growth in current year|Earnings per share growth rate in current year Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Net earnings per share growth this year|Earnings per share growth this year ZBIO|Net earnings per share growth this year IMNM|GOSS: Earnings per share increase in current year|Net earnings per share growth this year KALV (KalVista Pharmaceuticals, Inc.)|Net earnings per one share growth for the current year SEPN|Earnings growth in current year PVLA (Pieris Pharmaceuticals Inc)|Earnings per share increase in current year SVRA|Rigel Pharmaceuticals - Earnings growth in current year|Earnings per share growth rate in current year anaptysbio.com|Astria Therapeutics, Inc. (ATXS) - Earnings per share growth in current year|enGene Holdings Inc - Earnings per share increase in current year|RAPT (RAPT Therapeutics) - Earnings growth in current year|Earnings growth in current year Aerovate|Earnings per share growth in current year Aclaris Therapeutics (ACRS)|KYTX: Earnings per share trend in current year|Earnings growth in current year TLSA (Tiziana Life Sciences Ltd)|Cabaletta Bio Inc. (CABA) - Earnings per share growth rate in current year|VTYX: Net earnings per share growth this year|THTX - Earnings growth in current year|AVTX (Avalo Therapeutics, Inc) - Net earnings per share growth this year|ELDN: Net earnings per one share growth for the current year|AGEN (Agenus Inc.) - Earnings growth in current year|Climb Bio Inc. (CLYM) - Expected net earnings per share growth this year|Earnings growth in current year ZURA|Net earnings per share growth this year aTyr Pharmaceuticals ATYR|Earnings per share growth in current year Adagene Inc. ADAG|Expected net earnings per share growth this year ImageneBio (IMA)|Shattuck Therapeutics - Earnings growth in current year|Equillium, Inc. (EQ) - Net earnings per share growth this year|connectbiopharm.com (CNTB) - Earnings per share growth in current year|IMUX (Immunic) - Earnings per share growth in current year|ATRA (Atara Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth this year IFRX (InflaRx GmbH)|Net earnings per share growth this year XFOR (X4 Pharmaceuticals, Inc.)|adicetbio.com - Earnings per share growth this year|Earnings per share growth in current year Celularity CELU|INMB (INmune Bio Corporation) - Earnings per share trend in current year|Barinthus Biotherapeutics - Earnings growth in current year|Earnings per share increase in current year KZR (kezarlifesciences.com)|SABS: Earnings growth in current year|Akari Therapeutics PLC (AKTX) - Earnings growth in current year|Earnings per share growth in current year Enlivex Therapeutics Ltd|QTTB: Earnings per share increase in current year|Earnings per share growth in current year GeoVax Labs, Inc. (GOVX)|Net earnings per share growth this year edesabiotech.com EDSA|Earnings growth in current year IBIO (iBio)|Earnings growth in current year Carisma Therapeutics Inc CARM|XTLB: Net earnings per share growth this year|Earnings per share increase in current year BOLT (Bolt Biotherapeutics)|HCWB: Earnings growth in current year|APVO - Expected net earnings per share growth this year|Earnings per share growth in current year AIM ImmunoTech Inc.|Net earnings per share growth this year Aditxt Corp (ADTX)|Earnings per share growth in current year GRI Bio Corp (GRI)|Net earnings per share growth this year XORTX Corp XRTX|Vyome Holdings Inc - Net earnings per share growth this year|Earnings growth in current year revbiosciences.com REVB|INDP - Earnings per share growth in current year|SCNI (Scinai Immunotherapeutics Ltd) - Earnings per share growth this year|CALI: Earnings growth in current year|Earnings per share growth rate in current year Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Earnings growth in current year|Net earnings per share growth this year HOOKIPA (HOOK)|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings per share growth in current year Ocean Bio OCEA|TC BioPharm Ltd - Earnings per share growth in current year|THRD - Earnings per share growth in current year
